LA SCR31 | 2020 | Regular Session

Status

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on March 31 2020 - 25% progression, died in committee
Action: 2020-05-04 - Read second time by title and referred to the Committee on Commerce, Consumer Protection and International Affairs.
Pending: Senate Commerce, Consumer Protection, and International Affairs Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requests the Department of Economic Development and the Department of Revenue to develop an incentive package that will make Louisiana the domestic prescription drug manufacturing leader for the United States.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requests the Department of Economic Development and the Department of Revenue to develop an incentive package that will make Louisiana the domestic prescription drug manufacturing leader for the United States.

Sponsors


History

DateChamberAction
2020-05-04SenateRead second time by title and referred to the Committee on Commerce, Consumer Protection and International Affairs.
2020-03-31SenateIntroduced in the Senate. Read by title and placed on the Calendar for a second reading.

Subjects


Louisiana State Sources


Bill Comments

feedback